Journal
BIOMARKERS IN MEDICINE
Volume 11, Issue 1, Pages 69-86Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/bmm-2016-0195
Keywords
miRNA; nanoparticles; nanotechnology; oncology; sensors
Categories
Ask authors/readers for more resources
miRNAs are key regulators of gene expression, and alterations in their expression levels correlate with the onset and progression of cancer. Although miRNAs have been proposed as biomarkers for cancer diagnosis, their application in routine clinical praxis is yet to come. Current quantification strategies have limitation, and there is a great interest in developing innovative ones. Since a few years, nanotechnology-based approaches for miRNA quantification are emerging at fast pace but there is urgent need to go beyond the proof-of-concept stage. Nanotechnology will have a strong impact on cancer diagnosis through miRNA detection only if it is demonstrated that the newly developed approaches are indeed working on 'real-world' samples under standardized conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available